New insights into biomarkers for evaluating therapy efficacy in pulmonary tuberculosis: A narrative review

F Zhang, F Zhang, Y Dong, L Li, Y Pang - Infectious Diseases and Therapy, 2023 - Springer
Evaluating therapy efficacy is crucial for patients with tuberculosis (TB), especially those with
drug-resistant tuberculosis (DR-TB). The World Health Organization currently recommends …

Host and bacterial iron homeostasis, an underexplored area in tuberculosis biomarker research

L Baatjies, AG Loxton, MJ Williams - Frontiers in Immunology, 2021 - frontiersin.org
Mycobacterium tuberculosis (Mtb)“a human adapted pathogen” has found multiple ways to
manipulate the host immune response during infection. The human immune response to Mtb …

Identification of immune biomarkers in recent active pulmonary tuberculosis

SN Shaukat, E Eugenin, F Nasir, R Khanani… - Scientific reports, 2023 - nature.com
Tuberculosis (TB) has remained an unsolved problem and a major public health issue,
particularly in developing countries. Pakistan is one of the countries with the highest …

Potential Immunological Biomarker for Diagnosis and Prognosis of Tuberculosis

YA Hussain, KAS Mohammed, NH Ali - European Journal of …, 2023 - ej-biomed.org
Tuberculosis (TB) is one of the most common infectious diseases in the world, which has led
to numerous deaths. Hence, developing an efficient diagnostic method is essential to …

Avaliação do TNF-α como um potencial biomarcador para o diagnóstico da tuberculose pulmonar a partir da resposta induzida pelos lipídios do Mycobacterium …

AABS DANTAS - 2023 - repositorio.bahiana.edu.br
Atualmente, o diagnóstico da tuberculose (TB) depende de exames como a baciloscopia de
escarro que apresenta baixa sensibilidade e a cultura do escarro que pode levar até 45 …

[引用][C] New Insights into Biomarkers for Evaluating Therapy Efficacy in Pulmonary Tuberculosis: A Narrative

FZFZY Dong, LLY Pang - 2023 - europepmc.org
Evaluating therapy efficacy is crucial for patients with tuberculosis (TB), especially those with
drug-resistant tuberculosis (DR-TB). The World Health Organization currently recommends …